Detalhe da pesquisa
1.
Molecular Design of Squalene/Squalane Countertypes via the Controlled Oligomerization of Isoprene and Evaluation of Vaccine Adjuvant Applications.
Biomacromolecules
; 17(1): 165-72, 2016 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26652915
2.
MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Eur J Immunol
; 43(9): 2398-408, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23716300
3.
A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7.
J Nanobiotechnology
; 12: 17, 2014 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24766820
4.
High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis.
BMC Infect Dis
; 13: 331, 2013 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23870715
5.
Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity.
J Nanobiotechnology
; 11: 43, 2013 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24359024
6.
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions.
NPJ Vaccines
; 8(1): 14, 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36797262
7.
Screening of Oligomeric (Meth)acrylate Vaccine Adjuvants Synthesized via Catalytic Chain Transfer Polymerization.
Polymers (Basel)
; 15(18)2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37765685
8.
Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis.
J Immunol
; 185(3): 1701-10, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20601594
9.
Formulated Phospholipids as Non-Canonical TLR4 Agonists.
Pharmaceutics
; 14(12)2022 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36559051
10.
A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies.
Front Immunol
; 13: 1002430, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36389677
11.
Intranasal delivery of a synthetic Entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3 M-052 liposomes): In vitro characterization.
Int J Pharm
; 626: 122141, 2022 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058408
12.
Lyophilization Process Engineering and Thermostability of ID93 + GLA-SE, a Single-Vial Adjuvanted Subunit Tuberculosis Vaccine Candidate for Use in Clinical Studies.
Front Drug Deliv
; 22022.
Artigo
em Inglês
| MEDLINE | ID: mdl-37771324
13.
Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy.
Front Immunol
; 12: 683157, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34248966
14.
Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family.
Phytomedicine
; 64: 152927, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31465981
15.
Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.
Front Immunol
; 9: 295, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29515589
16.
Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica.
NPJ Vaccines
; 3: 22, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29900011
17.
A structure-function approach to optimizing TLR4 ligands for human vaccines.
Clin Transl Immunology
; 5(11): e108, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27990284
18.
Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii.
JCI Insight
; 1(15): e85955, 2016 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27699241
19.
In vitro evaluation of TLR4 agonist activity: formulation effects.
Colloids Surf B Biointerfaces
; 113: 312-9, 2014 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24121074
20.
Transcriptional profiling of TLR-4/7/8-stimulated guinea pig splenocytes and whole blood by bDNA assay.
J Immunol Methods
; 373(1-2): 54-62, 2011 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21839740